A protein that replaces the entire cellular eIF4F complex.

Department of Molecular Genetics and Microbiology and the Center for Infectious Diseases & Immunity, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
The EMBO Journal (Impact Factor: 10.75). 11/2008; 27(23):3129-39. DOI: 10.1038/emboj.2008.228
Source: PubMed

ABSTRACT The eIF4F cap-binding complex mediates the initiation of cellular mRNA translation. eIF4F is composed of eIF4E, which binds to the mRNA cap, eIF4G, which indirectly links the mRNA cap with the 43S pre-initiation complex, and eIF4A, which is a helicase necessary for initiation. Viral nucleocapsid proteins (N) function in both genome replication and RNA encapsidation. Surprisingly, we find that hantavirus N has multiple intrinsic activities that mimic and substitute for each of the three peptides of the cap-binding complex thereby enhancing the translation of viral mRNA. N binds with high affinity to the mRNA cap replacing eIF4E. N binds directly to the 43S pre-initiation complex facilitating loading of ribosomes onto capped mRNA functionally replacing eIF4G. Finally, N obviates the requirement for the helicase, eIF4A. The expression of a multifaceted viral protein that functionally supplants the cellular cap-binding complex is a unique strategy for viral mRNA translation initiation. The ability of N to directly mediate translation initiation would ensure the efficient translation of viral mRNA.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Pathogenic hantaviruses delay type I interferon response during early stages of viral infection. However, the robust interferon response and induction of interferon stimulated genes, observed during later stages of hantavirus infection fails to combat the virus replication in infected cells. Protein kinase R, a classical interferon stimulated gene product phosphorylates the eukaryotic translation initiation factor eIF2α and causes translation shutdown to create roadblocks for the synthesis of viral proteins. The PKR induced translation shutdown helps host cells to establish an antiviral state to interrupt virus replication. However, hantavirus infected cells do not undergo translation shutdown and fail to establish an antiviral state during the course of viral infection. Here we show for the first time that Andes virus infection induced PKR over-expression. However, the over-expressed PKR was not active due to significant inhibition of autophosphorylation. Further studies revealed that Andes virus nucleocapsid protein inhibited PKR dimerization, a critical step required for PKR autophosphorylation to attain activity. The studies reported here have established hantavirus nucleocapsid protein as a new PKR inhibitor. These studies have provided mechanistic insights for hantavirus resistance to host interferon response and have solved the puzzle for the lack of translation shutdown observed in hantavirus infected cells. The sensitivity of hantavirus replication to PKR has likely imposed a selective evolutionary pressure on hantaviruses to evade PKR antiviral response for survival. We envision that evasion of PKR antiviral response by NP has likely helped hantaviruses to exist during evolution and survive in infected hosts having multifaceted antiviral defense. Protein kinase R, a versatile antiviral host factor shuts down the translation machinery upon activation in virus-infected cells to create hurdles for the manufacture of viral proteins. The studies reported in this manuscript reveal that hantavirus nucleocapsid protein counteracts PKR antiviral response by inhibiting PKR dimerization, required for its activation. We report the discovery of a new PKR inhibitor whose expression in hantavirus infected cells prevents the PKR induced host translation shutdown to ensure the continuous synthesis of viral proteins, required for efficient virus replication. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
    Journal of Virology 11/2014; 89(3). DOI:10.1128/JVI.02347-14 · 4.65 Impact Factor
  • Source
    Viruses 04/2015; 7(4):1987-2005. DOI:10.3390/v7041987 · 3.28 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: How immunity to malaria develops remains one of the great unresolved issues in bio-medicine and resolution of its various paradoxes is likely to be the key to developing effective malaria vaccines. The basic epidemiological observations are; under conditions of intense natural transmission, humans do become immune to P. falciparum malaria, but this is a slow process requiring multiple disease episodes which many, particularly young children, do not survive. Adult survivors are immune to the symptoms of malaria, and unless pregnant, can control the growth of most or all new inoculations. Sterile immunity is not achieved and chronic parasitization of apparently healthy adults is the norm. In this article, we analyse the best understood malaria "antigenic variation" system, that based on Plasmodium falciparum's PfEMP1-type cytoadhesion antigens, and critically review recent literature on the function and control of this multi-gene family of parasite variable surface antigens.
    Advances in applied microbiology 01/2011; 74:77-96. DOI:10.1016/B978-0-12-387022-3.00007-0 · 2.24 Impact Factor


1 Download
Available from